BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29667589)

  • 1. A rare cause of dysregulated metabolic syndrome: cortisol-producing adrenocortical carcinoma.
    Saes L; Boere IA; Hofland J; Mulder M; Feelders RA
    Neth J Med; 2018 Apr; 76(3):129-131. PubMed ID: 29667589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of endothelin-1 by adrenocortical carcinoma: a new target for anti-cancer therapy?
    Donckier JE; Michel L; Delos M; Havaux X
    Acta Chir Belg; 2004 Oct; 104(5):581-3. PubMed ID: 15571028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disorganized Steroidogenesis in Adrenocortical Carcinoma, a Case Study.
    Uchida T; Nishimoto K; Fukumura Y; Asahina M; Goto H; Kawano Y; Shimizu F; Tsujimura A; Seki T; Mukai K; Kabe Y; Suematsu M; Gomez-Sanchez CE; Yao T; Horie S; Watada H
    Endocr Pathol; 2017 Mar; 28(1):27-35. PubMed ID: 27430645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerance of osilodrostat in patients with Cushing's syndrome due to adrenocortical carcinomas.
    Tabarin A; Haissaguerre M; Lassole H; Jannin A; Paepegaey AC; Chabre O; Young J
    Eur J Endocrinol; 2022 Jan; 186(2):K1-K4. PubMed ID: 34905500
    [No Abstract]   [Full Text] [Related]  

  • 5. Cushing's syndrome due to an adrenocortical carcinoma.
    Nag S; McCulloch A
    Postgrad Med J; 2003 Aug; 79(934):466. PubMed ID: 12954960
    [No Abstract]   [Full Text] [Related]  

  • 6. Co-secretion of aldosterone and cortisol by an adrenocortical carcinoma.
    Kurtulmus N; Yarman S; Azizlerli H; Kapran Y
    Horm Res; 2004; 62(2):67-70. PubMed ID: 15218335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma.
    Claps M; Cerri S; Grisanti S; Lazzari B; Ferrari V; Roca E; Perotti P; Terzolo M; Sigala S; Berruti A
    Endocrine; 2018 Jul; 61(1):169-172. PubMed ID: 29019062
    [No Abstract]   [Full Text] [Related]  

  • 8. Peripheral blood steroid levels in Cushing syndrome due to adrenocortical carcinoma or adenoma.
    Gabrilove JL; Freiberg EK; Nicolis GL
    Urology; 1983 Dec; 22(6):576-9. PubMed ID: 6649220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CUSHING'S SYNDROME CAUSED BY AN ADRENOCORTICAL CARCINOMA AFTER A BARIATRIC SURGERY: CASE REPORT.
    Souto KE; Pereira DA; Ramos MJ; Molinari AS; Damin Dde C
    Arq Bras Cir Dig; 2015; 28 Suppl 1(Suppl 1):87-9. PubMed ID: 26537284
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical characteristics of adrenocortical tumors in children.
    Chen QL; Su Z; Li YH; Ma HM; Chen HS; Du ML
    J Pediatr Endocrinol Metab; 2011; 24(7-8):535-41. PubMed ID: 21932594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant aldosterone-producing adrenal tumour: reoccurrence with glucocorticoid excess without hyperaldosteronism.
    Abma EM; Kluin PM; Dullaart RP
    Neth J Med; 2008 Jun; 66(6):252-5. PubMed ID: 18689909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of Cushing's syndrome due to adrenocortical carcinoma with recurrence 19 months after laparoscopic adrenalectomy.
    Ushiyama T; Suzuki K; Kageyama S; Fujita K; Oki Y; Yoshimi T
    J Urol; 1997 Jun; 157(6):2239. PubMed ID: 9146626
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: A case of Cushing's syndrome due to adrenocortical carcinoma with recurrence 19 months after laparoscopic adrenalectomy.
    Nelson JB; Kavoussi LR; Walther MM
    J Urol; 1998 Apr; 159(4):1310. PubMed ID: 9507868
    [No Abstract]   [Full Text] [Related]  

  • 14. Age-dependent decline in cortisol levels and clinical manifestations in patients with ACTH-independent Cushing's syndrome.
    Katayama M; Nomura K; Ujihara M; Obara T; Demura H
    Clin Endocrinol (Oxf); 1998 Sep; 49(3):311-6. PubMed ID: 9861321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldosterone-producing adrenocortical carcinoma without hypertension.
    Song MS; Seo SW; Bae SB; Kim YJ; Kim SJ
    Korean J Intern Med; 2012 Jun; 27(2):221-3. PubMed ID: 22707896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant regression of the tumor combined with the high level of plasma cortisol by low-dose administration of O, p'-DDD in a case with Cushing's syndrome caused by adrenocortical carcinoma.
    Otokida K; Nakamura M; Takeda M; Ito T; Kato M; Masuda T; Tashiro A
    Tohoku J Exp Med; 1986 Dec; 150(4):407-15. PubMed ID: 3564003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual large functional adrenocortical carcinoma in a young woman.
    Bansal A; Sankhwar S; Aeron R; Goel S
    BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26825939
    [No Abstract]   [Full Text] [Related]  

  • 18. Episodic secretion of cortisol in adrenocortical hyperplasia, adenoma and carcinoma.
    Lee YS; Chen FW
    Taiwan Yi Xue Hui Za Zhi; 1977 Feb; 76(2):166-70. PubMed ID: 266568
    [No Abstract]   [Full Text] [Related]  

  • 19. Ectopic expression of serotonin7 receptors in an adrenocortical carcinoma co-secreting renin and cortisol.
    Louiset E; Isvi K; Gasc JM; Duparc C; Cauliez B; Laquerrière A; Kuhn JM; Lefebvre H
    Endocr Relat Cancer; 2008 Dec; 15(4):1025-34. PubMed ID: 18708508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newly developed hypertension as an early marker of recurrence of adrenocortical carcinoma with high renin expression.
    Wen MJ; Lin YF; Chen JS
    Int J Urol; 2008 Jun; 15(6):540-2. PubMed ID: 18489644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.